^
+ Follow YOUTH WITH Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 210349
                    [Title] => No. 5 and  eyeing no. 4
                    [Summary] => Three years  since it was formed by the merger of Ciba Geigy and Sandoz. Novartis Healthcare Phils.  now generates the fifth largest revenues in the local pharmaceutical and health case industry. 


"We are behind United Laboratories, Glaxo-Smithkline, Pfizer, and Astra Zeneca," said Novartis country manager Leo Marchosky.

"We climbed up to the number five slot last year from number six, beating Roche."
[DatePublished] => 2003-06-16 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1125263 [AuthorName] => Angelica A. Angel [SectionName] => Business As Usual [SectionUrl] => business-as-usual [URL] => ) ) )
YOUTH WITH
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 210349
                    [Title] => No. 5 and  eyeing no. 4
                    [Summary] => Three years  since it was formed by the merger of Ciba Geigy and Sandoz. Novartis Healthcare Phils.  now generates the fifth largest revenues in the local pharmaceutical and health case industry. 


"We are behind United Laboratories, Glaxo-Smithkline, Pfizer, and Astra Zeneca," said Novartis country manager Leo Marchosky.

"We climbed up to the number five slot last year from number six, beating Roche."
[DatePublished] => 2003-06-16 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1125263 [AuthorName] => Angelica A. Angel [SectionName] => Business As Usual [SectionUrl] => business-as-usual [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with